Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06323473
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-21
First Post:
2024-02-27
Brief Title:
Maitake for Integrative Cancer Care
Sponsor:
The Canadian College of Naturopathic Medicine
Organization:
The Canadian College of Naturopathic Medicine
Study Overview
Official Title:
Maitake for Integrative Cancer Care An Open Label Uncontrolled Trial in People on Systemic Cancer Therapy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Maitake
Brief Summary:
Maitake is an edible mushroom that is used for both its nutritional and medicinal properties Human and animal studies have shown Maitake may help improve immune function however its effectiveness in people with cancer is not clear The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None